Treatment Indications: correction of pronounced wrinkles (deep nasolabial folds, marionette lines, glabellar lines);, facial volumization (cheeks, temples);, contouring (chin, jawline, nose bridge);, non-surgical rhinoplasty;, restoration of facial architecture and symmetry
Release form: 1 × 1.0 mL pre-filled sterile syringe
Compound: cross-linked hyaluronic acid (non-animal origin, produced via bacterial fermentation); phosphate-buffered saline solution; lidocaine
Concentration of GC: 20 mg/mL
Lidocaine: 0.3 %
Indications: injection into deep dermis and subcutaneous tissue;, provides structured volume, lift, and contouring with natural-looking results;, offers high viscoelasticity for stability in areas with significant muscular activity;, minimizes migration; effect duration approximately 9–12 months (in some cases up to 18 months)